No headlines found.
Globe Newswire (Thu, 21-Mar 9:00 PM ET)
AdaptHealth Corp. to Participate in the Barclays 26th Annual Global Healthcare Conference
Business Wire (Mon, 4-Mar 4:05 PM ET)
AdaptHealth Corp. to Participate in the 3rd Annual Jefferies Value Based Care Summit
Business Wire (Fri, 1-Mar 8:00 AM ET)
Business Wire (Tue, 27-Feb 7:00 AM ET)
Business Wire (Thu, 8-Feb 4:05 PM ET)
Globe Newswire (Wed, 7-Feb 9:00 AM ET)
Peloton Equity Leads Growth Investment in OnPoint Healthcare Partners
Business Wire (Thu, 25-Jan 2:18 PM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of March 28, 2024, AHCO stock price climbed to $11.51 with 844,660 million shares trading.
AHCO has a beta of 1.98, meaning it tends to be more sensitive to market movements. AHCO has a correlation of 0.12 to the broad based SPY ETF.
AHCO has a market cap of $1.57 billion. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $858 million in Revenue and $.49 earnings per share. This beat revenue expectation by $33 million and exceeded earnings estimates by $.31.
In the last 3 years, AHCO stock traded as high as $38.84 and as low as $6.37.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, IWM, VTI, VB, VXF.
AHCO stock has underperformed the market in the last year with a return of -17.1%, while SPY returned +33.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AHCO shares. However, AHCO has outperformed the market in the last 3 month and 2 week periods, returning +60.5% and +11.1%, while SPY returned +10.1% and +1.7%, respectively. This indicates AHCO has been having a stronger performance recently.
AHCO support price is $11.00 and resistance is $11.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO stock will trade within this expected range on the day.